Key facts
| Price (PPV) | 1,103 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | goséréline acétate |
| Class | Endocrine therapy |
| ATC code | L02AE03 |
| Manufacturer | MAPHAR |
| Presentation | Boîte de 1 seringue préremplie |
| Nature | Médicament |
| Hospital price | 827 MAD |
| Data collected on | 9/8/2026 |
Indications
Zoladex est indiqué chez l’adulte dans le : · Traitement du cancer de la prostate métastasé. · Traitement adjuvant à la radiothérapie externe dans le cancer de la prostate localement avancé (stade T3 -T4 de la classification TNM ou stade C de la classification AUA).
Find an open pharmacy
On-call pharmacies near you
About Zoladex 3.6 mg
Zoladex 3.6 mg belongs to the endocrine therapy therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Zoladex 3.6 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Zoladex 3.6 mg
Answers to common questions from Moroccan patients about this drug.